Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asset Turnover is linked to ROE % through Du Pont Formula. Arvee Laboratories (India)'s annualizedROE % for the quarter that ended in Dec. 2025 was 23.24%. It is also linked to ROA % through Du Pont Formula. Arvee Laboratories (India)'s annualizedROA % for the quarter that ended in Dec. 2025 was 18.01%.
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.
It is also linked to ROA % through Du Pont Formula:
Arvee Laboratories (India)'s annulizedROA % for the quarter that ended in Dec. 2025 is
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.
Arvee Laboratories (India) Asset Turnover Related Terms
Arvee Laboratories (India) Asset Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ARVEE vs LIN, SHW, ECL: Asset Turnover Comparison
For the Specialty Chemicals subindustry, Arvee Laboratories (India)'s Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvee Laboratories (India) Asset Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Arvee Laboratories (India)'s Asset Turnover distribution charts can be found below:
* The bar in red indicates where Arvee Laboratories (India)'s Asset Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.
Arvee Laboratories (India) (NSE:ARVEE) has a Asset Turnover of 0.24 as of Dec. 2025. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Arvee Laboratories (India) and its competitors.
Is Arvee Laboratories (India)'s Asset Turnover too high?
Arvee Laboratories (India)'s current Asset Turnover is 0.24. Overall, Arvee Laboratories (India) has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvee Laboratories (India)'s Asset Turnover compare to LIN and SHW?
Arvee Laboratories (India)'s Asset Turnover of 0.24 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Chemicals company?
A good Asset Turnover depends on the Chemicals industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Arvee Laboratories (India) and its competitors. Arvee Laboratories (India)'s current Asset Turnover is 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvee Laboratories (India) stock overvalued right now?
Based on GuruFocus' analysis, Arvee Laboratories (India) (NSE:ARVEE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹123.69, compared to a current price of ₹161.10 — trading 30.2% above its estimated fair value. The current Asset Turnover is 0.24. Arvee Laboratories (India)'s overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Arvee Laboratories (India) (NSE:ARVEE), the current Asset Turnover is 0.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvee Laboratories (India) (NSE:ARVEE) Overvalued in 2026?
Based on GuruFocus' analysis, Arvee Laboratories (India) stock appears to be overvalued.
The current stock price of ₹161.10 is trading 30.2% above its estimated GF Value™ of ₹123.69.
GuruFocus considers Arvee Laboratories (India) to be Modestly Overvalued.
Key valuation signals for NSE:ARVEE:
Asset Turnover: 0.24
GF Value™: ₹123.69 vs. price of ₹161.10 (30.2% above fair value)
No single metric tells the full story. See the NSE:ARVEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvee Laboratories (India) Ltd is a specialty chemical company. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
75GF Score
Get the complete analysis for NSE:ARVEE
Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ARVEE has been successfully added to your 
